# Subcutaneous Treatment With Icatibant for Acute Attacks of Hereditary Angioedema (HAE)

> **NCT00500656** · PHASE3 · COMPLETED · sponsor: **Shire** · enrollment: 85 (actual)

## Conditions studied

- Hereditary Angioedema

## Interventions

- **DRUG:** Icatibant
- **DRUG:** Tranexamic Acid
- **DRUG:** Oral Placebo
- **DRUG:** S.C. Placebo

## Key facts

- **NCT ID:** NCT00500656
- **Lead sponsor:** Shire
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-03-01
- **Primary completion:** 2006-07-25
- **Final completion:** 2006-07-25
- **Target enrollment:** 85 (ACTUAL)
- **Last updated:** 2021-06-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00500656

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00500656, "Subcutaneous Treatment With Icatibant for Acute Attacks of Hereditary Angioedema (HAE)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00500656. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*